The Riverside Company Invests in ACTINEO (German InsurTech)

Verisk Acquires ACTINEO from The Riverside Company

October 26, 2021

Data & Analytics

Verisk (Nasdaq: VRSK) has agreed to acquire ACTINEO GmbH, the German market leader in digitizing and medically assessing bodily injury claims, from The Riverside Company. The deal expands Verisk’s European claims-management and data-analytics capabilities and includes ACTINEO’s stake in joint venture ANTEVIS; the transaction is subject to customary closing conditions and regulatory approvals.

Bregal Unternehmerkapital Acquires Majority Stake in ACTICO

March 31, 2021

AI & Machine Learning

Funds advised by Bregal Unternehmerkapital acquired a majority stake in ACTICO, a Germany-based provider of intelligent automation and digital decision-making software. The investment will support ACTICO’s product development, market expansion and continued growth across banking, insurance and other regulated industries.

Rivean Capital Acquires Majority Stake in Acture Group from IK Partners

December 12, 2024

Healthcare Services

Rivean Capital has signed a definitive agreement to acquire a majority stake in Acture Group from IK Partners (IK Small Cap II), with Acture CEO Maudie Derks and the management team reinvesting alongside Rivean. Acture, headquartered in Nijmegen, Netherlands, is a provider of employee welfare and absence-management services (including case management, reintegration programmes and an absence insurance proposition) and employs roughly 390 full-time employees across the Netherlands and Germany. Rivean will support Acture's international growth and digital/product development to scale the business across Europe; completion is subject to regulatory and works council approvals.

The Riverside Company Invests in Avance Clinical

November 9, 2021

Healthcare Services

The Riverside Company has invested in Avance Clinical, a leading Australian contract research organisation (CRO), to support the company's regional and international expansion. The investment will help Avance accelerate its clinical trials business — including vaccine and gene-technology studies — with a particular focus on growth in North America and Asia.

ACTICO (BU-backed) Acquires Majority Stake in Fact Informationssysteme und Consulting

December 20, 2022

Software

ACTICO, a BU (Bregal Unternehmerkapital)-backed provider of intelligent automation software, has acquired a majority interest in Fact Informationssysteme und Consulting GmbH, a Neuss-based provider of investment-management software and consulting previously part of Software AG. The deal strengthens ACTICO’s RegTech platform for banks, insurers and other financial services providers by combining ACTICO’s automation and decisioning software with Fact’s specialist investment-administration and reporting capabilities.

Riverside's Red Nucleus Adds Actando SA

June 13, 2022

Healthcare Services

The Riverside Company’s Red Nucleus platform has completed an add-on acquisition of Actando SA, a Switzerland-headquartered provider of technology-enabled learning solutions for life sciences commercial teams. The deal expands Red Nucleus’ learning product portfolio and European footprint, strengthening its offering of scalable LMS, eLearning content and decision-making tools for global biopharma customers.